Current through Bulletin 2024-24, December 15, 2024
Section R590-287-5 - WAC HistoryThe reported WA C history shall include the following information:
(1) the name of the manufacturer;(2) the drug product's NDC;(3) a description of the drug product that includes the;(4) the FDA classification of the drug product as brand or generic;(5) the effective date of the WA C increase for the drug product;(6) the amount of the WA C increase for the drug product;(7) the WAC resulting from the reported cost increase for the drug product;(8) the WAC one calendar year prior to the effective date of the reported cost increase of the drug product;(9) the WA C two calendar years prior to the effective date of the reported cost increase of the drug product;(10) a written description, suitable for public release, of the factors that led to the increase in the WA C of the drug product and the significance of each factor; and(11) the manufacturer's aggregate company-wide research and development costs for the most recent year for which final audit data is available.Utah Admin. Code R590-287-5
Adopted by Utah State Bulletin Number 2022-11, effective 5/11/2022